Tirzepatide – 30mg Injection | Dual GLP-1 & GIP Receptor Agonist for Advanced Weight and Metabolic Management

Peptide Calculator

Description:

Tirzepatide is a next-generation peptide that activates both GLP-1 and GIP receptors to promote effective weight loss, appetite control, and improved blood sugar regulation. Its dual-action makes it a cutting-edge tool in metabolic health and body recomposition protocols.

Key Benefits:

Provides strong appetite suppression and reduced caloric intake
Enhances fat loss while preserving lean muscle
Improves insulin sensitivity and glycemic control
Supports metabolic balance during cutting or weight management
Administered via subcutaneous injection for efficient absorption

How It Works:

By activating both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, Tirzepatide regulates appetite, slows gastric emptying, and improves insulin secretion. This dual effect supports sustained weight loss and better blood sugar control.

Suggested Use:

Strength: 30mg per vial (multi-dose)
Typical Dose: Starting dose of 2.5mg once weekly, gradually increasing as tolerated (up to 15mg weekly or as prescribed)
Administration: Subcutaneous injection, typically once per week
Cycle Application: Primarily used for metabolic health, weight loss, and body composition support
Notes: Requires careful dose escalation

Product Specifications:

Strength: 30mg per vial
Volume: Multi-dose vial designed for weekly dosing
Storage: Store refrigerated between 2–8°C (36–46°F); protect from light